- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Português (Portugal)
- Polski
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
AptaBio Therapeutics Inc (293780)
AptaBio Therapeutics Inc stock price live, this page displays KQ 293780 stock exchange data. View the 293780 premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the AptaBio Therapeutics Inc real time stock price chart below.
What Is the AptaBio Therapeutics Inc Stock Price Today?
The AptaBio Therapeutics Inc stock price today is 9,150.
What Is the Stock Symbol for AptaBio Therapeutics Inc?
The stock symbol for AptaBio Therapeutics Inc is ""293780.""
What Stock Exchange Does AptaBio Therapeutics Inc Trade On?
AptaBio Therapeutics Inc is listed and trades on the KOSDAQ stock exchange.
Is AptaBio Therapeutics Inc a Good Stock to Buy?
Determining whether AptaBio Therapeutics Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the 293780 quote. (ISIN: KR7293780003)
What Is the AptaBio Therapeutics Inc Stock Price Today?
The AptaBio Therapeutics Inc stock price today is 9,150.
What Is the Stock Symbol for AptaBio Therapeutics Inc?
The stock symbol for AptaBio Therapeutics Inc is ""293780.""
What Stock Exchange Does AptaBio Therapeutics Inc Trade On?
AptaBio Therapeutics Inc is listed and trades on the KOSDAQ stock exchange.
Is AptaBio Therapeutics Inc a Good Stock to Buy?
Determining whether AptaBio Therapeutics Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the 293780 quote. (ISIN: KR7293780003)
KOSDAQ
Currency in KRW
9,150
+170(+1.89%)
Closed·
Fair Value
An estimate of a AptaBio Therapeutics's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
8,910
9,450
52 wk Range
5,750
14,560
293780 Scorecard
Full Analysis
Holds more cash than debt on its balance sheet
293780 is not included in our AI-picked strategies. See which stocks are.
Review Strategies
Fair Value
An estimate of a AptaBio Therapeutics's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
8,9109,450
52 wk Range
5,75014,560
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
293780 Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a AptaBio Therapeutics's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Neutral
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Stock has taken a big hit over the last week
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Sell
AptaBio Therapeutics Inc Company Profile
AptaBio Therapeutics Inc., a biopharmaceutical company, develops platform based drugs for intractable diseases. Its platforms include Oxidative stress modulation platform for developing therapeutic agents for diabetes complications, vascular diseases, neurodegenerative diseases, and intractable cancers by controlling oxidative stress; Cancer-associated fibroblast control platform for developing new anticancer drugs for intractable cancer; and Aptamer-drug conjugate platform for developing intractable anticancer drugs with high unmet medical needs. The company offers Lipofector-Q, Lipofector-EXT, Lipofector-2000, Lipofector-EZ, and Lipofector-pMAX reagents for transfecting DNA or RNA into eukaryotic cells. The company was founded in 2009 and is based in Yongin-si, South Korea.
Compare 293780 to Peers and Sector
Metrics to compare | 293780 | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship Relationship293780PeersSector | |
|---|---|---|---|---|
P/E Ratio | −9.0x | −9.1x | −0.5x | |
PEG Ratio | 0.07 | −0.08 | 0.00 | |
Price/Book | 4.8x | 2.7x | 2.6x | |
Price / LTM Sales | 80.7x | 20.7x | 3.2x | |
Upside (Analyst Target) | - | 0.0% | 40.5% | |
Fair Value Upside | Unlock | 9.3% | 4.4% | Unlock |
Earnings
Latest Release
May 15, 2025
EPS / Forecast
-95.96 / --
Revenue / Forecast
382.70M / --
FAQ
What Stock Exchange Does AptaBio Therapeutics Trade On?
AptaBio Therapeutics is listed and trades on the KOSDAQ stock exchange.
What Is the Stock Symbol for AptaBio Therapeutics?
The stock symbol for AptaBio Therapeutics is "293780."
What Is the AptaBio Therapeutics Market Cap?
As of today, AptaBio Therapeutics market cap is 241.39B.
What Is AptaBio Therapeutics's Earnings Per Share (TTM)?
The AptaBio Therapeutics EPS (TTM) is -1,126.65.
From a Technical Analysis Perspective, Is 293780 a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Neutral.
How Many Times Has AptaBio Therapeutics Stock Split?
AptaBio Therapeutics has split 1 times.
How Many Employees Does AptaBio Therapeutics Have?
AptaBio Therapeutics has 0 employees.
What is the current trading status of AptaBio Therapeutics (293780)?
As of 25 Jul 2025, AptaBio Therapeutics (293780) is trading at a price of 9,150.00, with a previous close of 8,980.00. The stock has fluctuated within a day range of 8,910.00 to 9,450.00, while its 52-week range spans from 5,750.00 to 14,560.00.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.